These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 21453686

  • 1. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T, Schnekenburger M, Ghelfi J, Walter J, Dicato M, Diederich M.
    Biochem Pharmacol; 2011 Jun 01; 81(11):1329-42. PubMed ID: 21453686
    [Abstract] [Full Text] [Related]

  • 2. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R, van Wert J, Bashambu M.
    Cancer Res; 2001 Jun 15; 61(12):4820-6. PubMed ID: 11406558
    [Abstract] [Full Text] [Related]

  • 3. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.
    Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 15; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X, Nelson WG.
    Cancer Res; 2003 Jan 15; 63(2):498-504. PubMed ID: 12543808
    [Abstract] [Full Text] [Related]

  • 8. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 15; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 10. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
    Rønneberg JA, Tost J, Solvang HK, Alnaes GI, Johansen FE, Brendeford EM, Yakhini Z, Gut IG, Lønning PE, Børresen-Dale AL, Gabrielsen OS, Kristensen VN.
    Cancer Res; 2008 Jul 15; 68(14):5562-71. PubMed ID: 18632608
    [Abstract] [Full Text] [Related]

  • 11. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.
    Clin Cancer Res; 2002 Apr 15; 8(4):1087-92. PubMed ID: 11948118
    [Abstract] [Full Text] [Related]

  • 12. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.
    Ann Hematol; 2007 Aug 15; 86(8):557-64. PubMed ID: 17508213
    [Abstract] [Full Text] [Related]

  • 13. Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer.
    Okino ST, Pookot D, Majid S, Zhao H, Li LC, Place RF, Dahiya R.
    Mol Carcinog; 2007 Oct 15; 46(10):839-46. PubMed ID: 17415778
    [Abstract] [Full Text] [Related]

  • 14. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
    Vidanes GM, Paton V, Wallen E, Peehl DM, Navone N, Brooks JD.
    Prostate; 2002 Jun 01; 51(4):225-30. PubMed ID: 11987150
    [Abstract] [Full Text] [Related]

  • 15. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
    Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ.
    Oncogene; 1999 Feb 11; 18(6):1313-24. PubMed ID: 10022813
    [Abstract] [Full Text] [Related]

  • 16. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
    Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ.
    Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822
    [Abstract] [Full Text] [Related]

  • 17. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 07; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z, Joh K, Yatsuki H, Zhao W, Soejima H, Higashimoto K, Noguchi M, Yokoyama M, Iwasaka T, Mukai T.
    Cancer Lett; 2007 Mar 18; 247(2):318-27. PubMed ID: 16806674
    [Abstract] [Full Text] [Related]

  • 19. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J, Lee HS, Bae SI, Lee YM, Kim WH.
    Anticancer Res; 2005 Mar 18; 25(6B):4013-9. PubMed ID: 16309193
    [Abstract] [Full Text] [Related]

  • 20. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
    Oncogene; 2005 Nov 24; 24(53):7946-52. PubMed ID: 16007117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.